Article info

Download PDFPDF
Absolute benefits of empagliflozin in type 2 diabetes: a game changer?

Authors

  1. Correspondence to Professor Cyrus R Kumana, Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong; hrmekcr{at}hku.hk
View Full Text

Citation

Kumana CR, Tan KCB, Cheung BMY
Absolute benefits of empagliflozin in type 2 diabetes: a game changer?

Publication history

  • Received December 13, 2016
  • Revised March 10, 2017
  • Accepted March 13, 2017
  • First published April 22, 2017.
Online issue publication 
June 28, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.